Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticoagulation in dilated cardiomyopathy

L S Koniaris1, S Z Goldhaber

  • 1Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, USA.

Journal of the American College of Cardiology
|April 3, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sulodexide in venous disease.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Prevention and treatment of venous thromboembolism--International Consensus Statement.

International angiology : a journal of the International Union of Angiology·2014
Same journal

Aortic Valve Replacement in Women of Reproductive Age.

Journal of the American College of Cardiology·2026
Same journal

Sudden Death in Cardio-Kidney-Metabolic Patients: Insights From FINE-HEART.

Journal of the American College of Cardiology·2026
Same journal

Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.

Journal of the American College of Cardiology·2026
Same journal

Reframing Cardiometabolic Risk and Frailty Through Sarcopenic Obesity.

Journal of the American College of Cardiology·2026
Same journal

Imaging-Derived Sarcopenic Obesity and Cardiovascular Outcomes: Insights Into Heart Failure Risk and Muscle Biology.

Journal of the American College of Cardiology·2026
Same journal

The Measure of a Leader: Lessons in Leadership From Eugene Braunwald.

Journal of the American College of Cardiology·2026
See all related articles

Patients with dilated cardiomyopathy face high risks of thromboembolic events. A national registry may offer practical insights into anticoagulation effectiveness and bleeding risks, avoiding a large clinical trial.

Area of Science:

  • Cardiology
  • Thrombosis
  • Pharmacology

Background:

  • Patients with dilated cardiomyopathy (DCM) exhibit numerous risk factors for thromboembolic events.
  • Existing data on the incidence of these events in DCM patients is highly variable.
  • There is a lack of controlled studies evaluating long-term anticoagulation in DCM with congestive heart failure.

Purpose of the Study:

  • To review existing literature on thromboembolic event risks in dilated cardiomyopathy.
  • To assess the efficacy and safety of anticoagulation therapy in this patient group.
  • To propose an alternative data collection strategy for evaluating anticoagulation in DCM.

Main Methods:

  • Systematic review of published data on thromboembolic events in dilated cardiomyopathy.

Related Experiment Videos

  • Analysis of reported effectiveness and risks associated with anticoagulation.
  • Proposal for a national registry to collect observational data.

    • Main Results:

    • The incidence of thromboembolic events in dilated cardiomyopathy patients varies significantly across studies.
    • Anticoagulation's role in reducing these events and its associated bleeding risks require further clarification.
    • A national registry is suggested as a feasible method to gather comprehensive data.

    Conclusions:

    • Further research is needed to establish optimal anticoagulation strategies for dilated cardiomyopathy.
    • A national registry offers a practical approach to collecting crucial data on thromboembolism and bleeding.
    • Observational data from a registry can inform clinical practice regarding anticoagulation in DCM.